Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cancer Cachexia, NSCLC Cachexia Performance Status

Jeffrey Crawford

MD

🏢Duke University Medical Center🌐USA

Professor and Chief of Oncology

57
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Jeffrey Crawford has conducted landmark clinical research in cancer cachexia, including trials of selective androgen receptor modulators (SARMs) such as enobosarm for muscle preservation in NSCLC patients. He has contributed to defining appropriate clinical trial endpoints for cachexia including muscle mass and function measures. His work on the interaction between performance status, cachexia, and cancer treatment tolerability has influenced practice guidelines.

Share:

🧪Research Fields 研究领域

NSCLC cancer cachexia clinical management
performance status cachexia NSCLC
enobosarm SARM cachexia
cancer cachexia clinical trial endpoints
mealtime cancer appetite interventions

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Jeffrey Crawford 的研究动态

Follow Jeffrey Crawford's research updates

留下邮箱,当我们发布与 Jeffrey Crawford(Duke University Medical Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment